Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Geoff Meacham
Recent news which mentions Geoff Meacham
Eli Lilly's Upcoming Obesity Drugs Highlight Bright Future, Says Optimistic Analyst
October 06, 2023
Tickers
LLY
Tags
Price Target
Expert Ideas
Movers
From
Benzinga
Gilead Sciences Shares Trade Higher After Bullish Analyst Upgrades Stock
September 08, 2023
Tickers
BAC
GILD
Tags
News
Large Cap
Trading Ideas
From
Benzinga
Merck Vs. Pfizer: Why Analyst Upgrades One Pharmaceutical Stock, While Downgrading Another
January 04, 2023
Tickers
MRK
PFE
Tags
Geoff Meacham
Market News
Analyst Color
From
Benzinga
7 Biogen Analysts On Alzheimer's Drug Success As Stock Skyrockets 37%
September 28, 2022
Tickers
BIIB
Tags
Morgan Stanley
Steve Chesney
Movers
From
Benzinga
Why These Pfizer Analysts Like The Global Blood Therapeutics Deal
August 08, 2022
Tickers
BHVN
BNTX
GBT
PFE
Tags
Analyst Ratings
Analyst Color
BNTX
From
Benzinga
Pfizer, Moderna Analysts Respond To FDA COVID Booster Ruling: 'Revenues Will Decline'
June 29, 2022
Tickers
BNTX
MRNA
NVAX
PFE
Tags
FDA
Karen Anderson
NVAX
From
Benzinga
10 Investor Questions About COVID-19, Answered
April 03, 2022
Tickers
JNJ
MRNA
NVAX
PFE
Tags
Bank of America
Top Stories
Health Care
From
Benzinga
Ahead Of Moderna's Midstage mRNA Flu Vaccine Readout, Analyst Says Drugmaker Likely To Be First To Market
March 21, 2022
Tickers
GSK
MRNA
PFE
SNY
Tags
Biotech
Benzinga
PFE
From
Benzinga
Why This Analyst Has Increased Confidence In Inovio Pharmaceuticals
January 21, 2022
Tickers
INO
Tags
News
BofA Securities
pharmaceuticals
From
Benzinga
BofA Downgrades CureVac On Limited 2022 Prospects
January 21, 2022
Tickers
CVAC
Tags
Geoff Meacham
Market News
Analyst Color
From
Benzinga
BofA Bullish On This Gene Therapy Biotech Transitioning Into A Commercial Enterprise
January 18, 2022
Tickers
KRYS
Tags
Benzinga
Biotech
Small Cap
From
Benzinga
Why This Pfizer, Regeneron Analyst Has Contrasting Recommendations For The COVID Stock Plays
January 05, 2022
Tickers
PFE
REGN
Tags
REGN
Price Target
PFE
From
Benzinga
How Much Revenue Could Pfizer's Oral COVID-19 Pill Fetch?
December 23, 2021
Tickers
MRK
PFE
Tags
Paxlovid
General
Biotech
From
Benzinga
3 Biopharma Stocks To Watch Following Johnson & Johnson's Earnings Beat
October 19, 2021
Tickers
ABBV
AMGN
JNJ
LLY
Tags
Reiteration
Trading Ideas
Earnings
From
Benzinga
How To Play Moderna Stock Ahead Of Key FDA COVID-19 Booster Shot Ruling
October 12, 2021
Tickers
MRNA
PFE
Tags
PFE
Covid/19
Price Target
From
Benzinga
Merck's Oral COVID-19 Treatment Could Be Game-Changer: BofA Analyst
October 06, 2021
Tickers
BNTX
JNJ
MRK
MRNA
Tags
Coronavirus
Reiteration
BofA Securities
From
Benzinga
Moderna Analysts Debate Need For Biopharma's COVID-19 Booster Shot
September 16, 2021
Tickers
BNTX
MRNA
PFE
Tags
Price Target
Covid/19
PFE
From
Benzinga
Rani Therapeutics, RxSight: 2 Bullish Health Care Stock Picks From BofA
August 24, 2021
Tickers
RANI
RXST
Tags
Health Care
BofA Securities
Trading Ideas
From
Benzinga
Moderna's Stock Valuation Goes From 'Unreasonable To Ridiculous': Analyst
August 10, 2021
Tickers
AMGN
BMY
MRK
MRNA
Tags
vaccine
General
Biotech
From
Benzinga
Graphite Bio's Approach To Gene Editing Has BofA Securities and Morgan Stanley Bullish
July 20, 2021
Tickers
GENE
GRPH
Tags
Market News
Geoff Meacham
Analyst Color
From
Benzinga
These 3 New Biotechs Have Differentiated Platforms, Technology: BofA
July 13, 2021
Tickers
AMAM
CYT
IPSC
Tags
Market News
Geoff Meacham
Analyst Color
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.